Coeptis Therapeutics (COEP) Holdings announced it has regained compliance with Listing Rule 5550, as required by the Nasdaq Hearings Panel’s decision of September 17, 2024.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COEP:
- Coeptis Therapeutics Holdings Inc trading resumes
- Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
- Coeptis Therapeutics Holdings Inc trading halted, news pending
- Upcoming Stock Splits This Week (December 30 to January 3) – Stay Invested
- Coeptis Therapeutics announces 1-for-20 reverse stock split